Dr. Kallmes and colleagues reply

New England Journal of Medicine

Volumn 361, Issue 21, 2009, Pages 2099-2100

  Kallmes, David F ^a   Heagerty, Patrick J ^b   Jarvik, Jeffrey G ^b  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE SEVERITY; EDEMA; FRACTURE; HUMAN; LETTER; PAIN; PERCUTANEOUS VERTEBROPLASTY; PRIORITY JOURNAL; TREATMENT DURATION;

EID: 70949106265     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. Diamond TH, Champion B, Clark WA. Management of acute osteoporotic vertebral fractures: a nonrandomized trial comparing percutaneous vertebroplasty with conservative therapy. Am J Med 2003;114:25765. (Pubitemid 36398069)
2. Rousing R, Andersen MO, Jespersen SM, Thomsen K, Lauritsen J. Percutaneous vertebroplasty compared to conservative treatment in patients with painful acute or subacute osteoporotic vertebral fractures: three-months follow-up in a clinical randomized study. Spine 2009;34:134954.
3. Wardlaw D, Cummings SR, Van Meirhaeghe J, et al. Efficacy and safety of balloon kyphoplasty compared with non-surgical care for vertebral compression fracture (FREE): a randomised controlled trial. Lancet 2009;373:101624.
4. Kallmes DF, Comstock BA, Gray LA, et al. Baseline pain and disability in the Investigational Vertebroplasty Efficacy and Safety Trial. AJNR Am J Neuroradiol 2009;30:12035.
5. Lane JI, Maus TP, Wald JT, Thielen KR, Bobra S, Leutmer PH. Intravertebral clefts opacified during vertebroplasty: pathogenesis, technical implications, and prognostic significance. AJNR Am J Neuroradiol 2002;23:16426.